Kah Keng Wong

Employment

• Universiti Sains Malaysia Associate Professor
  2019 - Present
• Universiti Sains Malaysia University Lecturer
  2011 - 2019
• Citibank Contract Officer
  2007 - 2007
• University of Malaya Research Assistant
  2006 - 2007
• Citibank Data Inputer
  2002 - 2003

Education

• University of Oxford DPhil
  2007 - 2011
• University of Malaya BSc (1st Hons)
  2003 - 2006

Projects & Funding

Projects & funding information is unavailable.

Publications (115)

• cepip: Cell Explanatory Power with Inflection Point (CEP-IP) with CMRF
  Zenodo 2026 DOI: 10.5281/zenodo.23884524
  +Save
• CEP-IP with CMRF in SEA-AD Microglia: A Mitochondrial Co-expression Module Linked to Cognition
  2026 DOI: 10.64898/2026.10.22.761284
  +Save
• CEP-IP with CMRF in SEA-AD Microglia: A Mitochondrial Co-expression Module Linked to Cognition
  Zenodo 2026 DOI: 10.5281/zenodo.23445742
  +Save
• CEP-IP with CMRF in SEA-AD Microglia: Analysis Code and Software Environment
  Zenodo 2026 DOI: 10.5281/zenodo.23446228
  +Save
• CEP-IP: An explainable framework for cell subpopulation identification in single-cell transcriptomics
  Computer Methods and Programs in Biomedicine 2026 DOI: 10.1016/j.cmpb.2026.109372
  +Save
• MAGE-A in triple-negative breast cancer: molecular biology, epigenetic targeting, and immunotherapy
  Epigenomics 2025 DOI: 10.1080/17501911.2025.2595910
  +Save
• Antibody-drug conjugates in breast cancer: From therapeutic and immune activation mechanisms to resistance prevention
  International Reviews of Immunology 2025 DOI: 10.1080/08830185.2025.2545364
  +Save
• CEP-IP: An Explainable Framework for Cell Subpopulation Identification in Single-cell Transcriptomics
  arXiv e-prints 2025 DOI: 10.48550/arXiv.2509.12073
  +Save
• Multiomics in silico analysis identifies TM4SF4 as a cell surface target in hepatocellular carcinoma
  PLOS ONE 2025 DOI: 10.1371/journal.pone.0307048
  +Save
• Ensemble machine learning and tree-structured Parzen estimator to predict early-stage pancreatic cancer
  Biomedical Signal Processing and Control 2025 DOI: 10.1016/j.bspc.2025.107867
  +Save
• Hypomethylating agents as emerging therapeutics for triple-negative breast cancer
  Life Sciences 2025 DOI: 10.1016/j.lfs.2025.123403
  +Save
• Multiomics data analysis identifies TM4SF4 as a cell surface target in hepatocellular carcinoma
  2024 DOI: 10.1101/2024.07.01.601537
  +Save
• Association between Low Vitamin D Levels and Key Characteristics of COVID-19 Patients: A Retrospective Cross-sectional Study
  Malaysian Journal of Medicine and Health Sciences 2024 DOI: 10.47836/mjmhs.20.3.4
  +Save
• Tree-structured Parzen estimator and ensemble machine learning to predict early-stage pancreatic cancer
  SSRN 2024 DOI: 10.2139/ssrn.4809282
  +Save
• Work intensity and fat mass percentage are associated with asymptomatic morphometric vertebral fractures in knee osteoarthritis patients: A cross-sectional study
  Plos One 2024 DOI: 10.1371/journal.pone.0308746
  +Save
• Editorial: A new frontier for traditional medicine research—Multi-omics approaches
  Frontiers in Pharmacology 2023 DOI: 10.3389/fphar.2023.1203097
  +Save
• Integrated transcriptomics and proteomics data analysis identifies CDH17 as a key cell surface target in colorectal cancer
  Computational Biology and Chemistry 2023 DOI: 10.1016/j.compbiolchem.2023.107897
  +Save
• Margetuximab and trastuzumab deruxtecan: New generation of anti-HER2 immunotherapeutic agents for breast cancer
  Elsevier 2022
  +Save
• Strobilanthes crispus elicits anti-tumor immunogenicity in in vitro and in vivo metastatic breast carcinoma.
  PloS one 2022 DOI: 10.1371/journal.pone.0271203
  +Save
• CDH17 as a Cell Surface Immunotherapy Target in Colorectal Cancer: An In Silico Analysis
  [] 2022 DOI: 10.21203/rs.3.rs-1894271/v1
  +Save